BIO-TECHNE Corp — Director's Dealing 2013

Aug 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-08-01

Reporting Person: REAGAN KEVIN J (Senior VP Biotech)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-08-01	Stock Option (Right to Buy)	$76.02	A	15000	Acquired	2020-07-31	Common Stock (15000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$70.96	2019-01-23	Common Stock (10773)	10773	Direct
Stock Option (Right to Buy)	$70.96	2019-01-23	Common Stock (4227)	4227	Direct
Stock Option (Right to Buy)	$74.05	2019-07-26	Common Stock (516)	516	Direct

Footnotes

F1: Vests 3,591 on each of 1/24/13, 1/24/14, and 1/24/15.

F2: Vests 1,409 on each of 1/24/13, 1/24/14, and 1/24/15.

F3: Fully exercisable.

F4: Vests 3,750 on each of 8/1/14, 8/1/15, 8/1/16, and 8/1/17.